IC/BPS-Therapie: neuartiger SHIP1-Aktivator ohne Erfolg

[Article in German]

No authors listed

Comment

[Article in German]

No authors listed. Aktuelle Urol. 2020 Dec.

. 2020 Dec;51(6):518-520.

doi: 10.1055/a-0962-5910. Epub 2020 Nov 24.

No abstract available

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome.
Nickel JC, Moldwin R, Hanno P, Dmochowski R, Peters KM, Payne C, Wein A. Nickel JC, et al. J Urol. 2019 Aug;202(2):301-308. doi: 10.1097/JU.0000000000000192. Epub 2019 Jul 8. J Urol. 2019. PMID: 31090511 Clinical Trial.